DE60121032D1 - Heterocyclische sulfonamide als inhibitoren der beta-amyloid-produktion - Google Patents

Heterocyclische sulfonamide als inhibitoren der beta-amyloid-produktion

Info

Publication number
DE60121032D1
DE60121032D1 DE60121032T DE60121032T DE60121032D1 DE 60121032 D1 DE60121032 D1 DE 60121032D1 DE 60121032 T DE60121032 T DE 60121032T DE 60121032 T DE60121032 T DE 60121032T DE 60121032 D1 DE60121032 D1 DE 60121032D1
Authority
DE
Germany
Prior art keywords
inhibitors
beta
amyloid production
sulphonamides
heterocyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60121032T
Other languages
English (en)
Other versions
DE60121032T2 (de
Inventor
Anthony Frank Kreft
Derek Cecil Cole
Kevin Roger Woller
Joseph Raymond Stock
George Diamanitis
Dennis Michael Kurbrak
Kristina Martha Kutterer
William Jay Moore
David Scott Casebier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Arqule Inc
Original Assignee
Wyeth LLC
Arqule Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22966854&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60121032(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth LLC, Arqule Inc filed Critical Wyeth LLC
Publication of DE60121032D1 publication Critical patent/DE60121032D1/de
Application granted granted Critical
Publication of DE60121032T2 publication Critical patent/DE60121032T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/64—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms
DE60121032T 2000-12-13 2001-12-11 Heterocyclische sulfonamide als inhibitoren der beta-amyloid-produktion Expired - Lifetime DE60121032T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25510500P 2000-12-13 2000-12-13
US255105P 2000-12-13
PCT/US2001/048375 WO2002057252A2 (en) 2000-12-13 2001-12-11 Heterocyclic sulfonamide inhibitors of beta amyloid production

Publications (2)

Publication Number Publication Date
DE60121032D1 true DE60121032D1 (de) 2006-08-03
DE60121032T2 DE60121032T2 (de) 2007-01-11

Family

ID=22966854

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60121032T Expired - Lifetime DE60121032T2 (de) 2000-12-13 2001-12-11 Heterocyclische sulfonamide als inhibitoren der beta-amyloid-produktion

Country Status (28)

Country Link
US (5) US6610734B2 (de)
EP (1) EP1341779B1 (de)
JP (2) JP2004517892A (de)
KR (1) KR100869061B1 (de)
CN (2) CN1800176A (de)
AR (1) AR035516A1 (de)
AT (1) ATE330950T1 (de)
AU (1) AU2002245123B2 (de)
BR (1) BR0116063A (de)
CA (1) CA2436526C (de)
CY (1) CY1105441T1 (de)
DE (1) DE60121032T2 (de)
DK (1) DK1341779T3 (de)
EA (1) EA009035B1 (de)
ES (1) ES2267853T3 (de)
HK (1) HK1059619A1 (de)
HU (1) HUP0303857A3 (de)
IL (3) IL156268A0 (de)
MX (1) MXPA03005255A (de)
NO (1) NO328885B1 (de)
NZ (2) NZ538100A (de)
PL (1) PL365950A1 (de)
PT (1) PT1341779E (de)
SG (1) SG128491A1 (de)
SI (1) SI1341779T1 (de)
TW (1) TWI235155B (de)
WO (1) WO2002057252A2 (de)
ZA (1) ZA200304135B (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4086101A (en) * 2000-03-20 2001-10-03 Merck Sharp & Dohme Sulphonamido-substituted bridged bicycloalkyl derivatives
US6657070B2 (en) 2000-12-13 2003-12-02 Wyeth Production of chirally pure α-amino acids and N-sulfonyl α-amino acids
ATE330950T1 (de) * 2000-12-13 2006-07-15 Wyeth Corp Heterocyclische sulfonamide als inhibitoren der beta-amyloid-produktion
AU2002359519B2 (en) 2001-12-11 2009-07-16 Wyeth Process for the synthesis of chirally pure beta-amino-alcohols
NZ536665A (en) * 2002-06-11 2006-11-30 Wyeth Corp Use of substituted phenylsulfonamide as inhibitors of beta amyloid production
JP4494212B2 (ja) * 2002-11-12 2010-06-30 メルク・シャープ・エンド・ドーム・コーポレイション アルツハイマー病の治療用フェニルカルボキサミドベータセクレターゼ阻害剤
JP2006522126A (ja) 2003-03-31 2006-09-28 ワイス βアミロイド生産のフルオロ含有およびトリフルオロアルキル含有複素環スルホンアミド阻害物質およびその誘導体
PL379466A1 (pl) * 2003-06-30 2006-09-18 Daiichi Sankyo Company , Limited Heterocykliczne pochodne metylosulfonu
WO2005073198A1 (en) * 2004-01-16 2005-08-11 Wyeth Heterocyclic sulfonamide inhibitors of beta amyloid production containing an azole
EP1838701A1 (de) 2005-01-18 2007-10-03 Elan Pharmaceuticals Inc. N-substituierte heterocyclische sulfonamide
CA2600570C (en) * 2005-03-14 2011-12-06 Transtech Pharma, Inc. Benzazole derivatives, compositions, and methods of use as .beta.-secretase inhibitors
TW200800959A (en) * 2005-06-10 2008-01-01 Wyeth Corp Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor
GB0602951D0 (en) * 2006-02-14 2006-03-29 Novartis Ag Organic Compounds
RU2008129797A (ru) * 2006-02-17 2010-03-27 Вайет (Us) Способы получения сульфонамид-замещенных спиртов и их промежуточных соединений
WO2007098030A1 (en) * 2006-02-17 2007-08-30 Wyeth Selective n-sulfonylation of 2-amino trifluoroalkyl substituted alcohols
US7476762B2 (en) * 2006-04-21 2009-01-13 Wyeth Methods for preparing sulfonamide compounds
BRPI0710470A2 (pt) * 2006-04-21 2011-08-16 Wyeth Corp métodos para preparar seletivamente um aminoálcool quiral e uma sulfonamida quiral
US7550629B2 (en) * 2006-04-21 2009-06-23 Wyeth Trifluoromethyl-containing phenylsulfonamide beta amyloid inhibitors
TW200808740A (en) * 2006-06-09 2008-02-16 Wyeth Corp Succinate salts of 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline and crystalline forms thereof
TW200808741A (en) * 2006-06-09 2008-02-16 Wyeth Corp 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline hydrochloric acid salts
TW200811144A (en) * 2006-06-09 2008-03-01 Wyeth Corp Crystalline forms of 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline
WO2008059238A1 (en) * 2006-11-17 2008-05-22 Astrazeneca Ab Benzenesulfonamide compounds as edg-1 antagonists useful in the treatment of cancer
EP2099741A2 (de) * 2006-11-21 2009-09-16 University Of Virginia Patent Foundation Hydrindan-analoga mit sphingosin-1-phosphatrezeptoragonistenaktivität
TW200831096A (en) * 2006-11-28 2008-08-01 Wyeth Corp Metabolites of 5-Fluoro-8-{4-[4-(6-methoxyquinolin-8-yl)piperazin-1-yl]piperidin-1-yl} quinoline and methods of preparation and uses thereof
CL2008000119A1 (es) * 2007-01-16 2008-05-16 Wyeth Corp Compuestos derivados de pirazol, antagonistas del receptor nicotinico de acetilcolina; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como demencia senil, alzheimer y esquizofrenia.
US20100204230A1 (en) 2007-02-12 2010-08-12 Peter Blurton Piperazine derivatives for treatment of ad and related conditions
PA8789601A1 (es) * 2007-07-16 2009-02-09 Wyeth Corp Proceso para la preparación de trifluoralquil-fenil sulfonamidas y de sulfonamidas heterocíclicas
AR067533A1 (es) * 2007-07-16 2009-10-14 Wyeth Corp Procesos e inetermediarios para la preparacion de compuestos de sulfonamida heterociclica
US20090023801A1 (en) * 2007-07-16 2009-01-22 Wyeth Inhibitors of beta amyloid production
CN101945853B (zh) 2007-12-21 2014-08-20 配体药物公司 选择性雄激素受体调节剂(sarm)及其应用
WO2009089237A1 (en) * 2008-01-11 2009-07-16 Wyeth Compositions containing o-sulfate and o-phosphate containing aryl sulfonamide derivatives useful as beta-amyloid inhibitors
EP2291181B9 (de) 2008-04-18 2013-09-11 University College Dublin National University Of Ireland, Dublin Captodiamine zur Behandlung von depressionartigen Symptomen
EP2328572B1 (de) 2008-07-28 2018-06-13 Blanchette Rockefeller Neurosciences, Institute Pkc-aktivierende verbindungen zur behandlung von neurodegenerativen erkrankungen
MX2012006962A (es) 2009-12-17 2012-07-17 Merck Patent Gmbh Inhibidores de la esfingosina quinasa.
US9802954B2 (en) 2011-08-24 2017-10-31 Boehringer Ingelheim International Gmbh Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma
AU2014207408C1 (en) 2013-01-18 2018-09-06 Cardioxyl Pharmaceuticals, Inc. Pharmaceutical compositions comprising nitroxyl donors
CN104370769B (zh) * 2013-08-14 2017-05-31 重庆博腾制药科技股份有限公司 一种制备羟基金刚烷甘氨酸衍生物的方法
WO2015108988A2 (en) 2014-01-17 2015-07-23 Ligand Pharmaceuticals, Inc. Methods and compositions for modulating hormone levels
WO2017155890A1 (en) * 2016-03-11 2017-09-14 Ohio State Innovation Foundation Novel small molecule antimicrobials
DE202022106287U1 (de) 2022-11-09 2022-11-21 Ahmad Salawi Eine Methode zur Synthese und biologischen Bewertung von neuen Sulfonamid-Analoga

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US656536A (en) * 1899-12-28 1900-08-21 David Fitzgibbons Boiler.
US3376523A (en) * 1966-12-27 1968-04-02 Univ California Transient-suppressing magnetic transmission line
US5464853A (en) 1993-05-20 1995-11-07 Immunopharmaceutics, Inc. N-(5-isoxazolyl)biphenylsulfonamides, N-(3-isoxazolyl)biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
US5594021A (en) 1993-05-20 1997-01-14 Texas Biotechnology Corporation Thienyl-, furyl- and pyrrolyl sulfonamides and derivatives thereof that modulate the activity of endothelin
US5514691A (en) 1993-05-20 1996-05-07 Immunopharmaceutics, Inc. N-(4-halo-isoxazolyl)-sulfonamides and derivatives thereof that modulate the activity of endothelin
US5591761A (en) 1993-05-20 1997-01-07 Texas Biotechnology Corporation Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US5571821A (en) 1993-05-20 1996-11-05 Texas Biotechnology Corporation Sulfonamides and derivatives thereof that modulate the activity of endothelin
EP0510700A3 (en) 1991-04-26 1992-12-16 Takeda Chemical Industries, Ltd. Azole compounds, their production and use
GB9110722D0 (en) 1991-05-17 1991-07-10 Fujisawa Pharmaceutical Co Amine derivatives
US5766846A (en) 1992-07-10 1998-06-16 Athena Neurosciences Methods of screening for compounds which inhibit soluble β-amyloid peptide production
US5968942A (en) 1992-08-25 1999-10-19 G. D. Searle & Co. α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
JP3599287B2 (ja) * 1993-04-28 2004-12-08 三菱化学株式会社 スルホンアミド誘導体
US6342610B2 (en) * 1993-05-20 2002-01-29 Texas Biotechnology Corp. N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US6376523B1 (en) 1994-05-20 2002-04-23 Texas Biotechnology Corporation Benzenesulfonamides and the use thereof to modulate the activity of endothelin
CZ184194A3 (en) 1993-08-09 1995-03-15 Lilly Co Eli Aspartylprotease inhibitor and method of identifying thereof
US5519040A (en) 1994-04-29 1996-05-21 Allergan Substituted thiazole sulfonamides as antiglaucoma agents
US5561146A (en) * 1994-06-10 1996-10-01 Bristol-Myers Squibb Company Modified guanidino and amidino thrombin inhibitors
US5624937A (en) 1995-03-02 1997-04-29 Eli Lilly And Company Chemical compounds as inhibitors of amyloid beta protein production
EP0761680A3 (de) * 1995-09-12 1999-05-06 Ono Pharmaceutical Co., Ltd. Tetrazolverbindungen mit Interleukin-1beta-konvertierendes Enzym inhibierende Aktivität
JPH09136878A (ja) * 1995-09-12 1997-05-27 Ono Pharmaceut Co Ltd テトラゾール誘導体
EP0910564B1 (de) * 1995-11-28 2007-10-31 Cephalon, Inc. Aus d-aminosäuren abgeleitete cystein- und serinproteasehemmer
JPH09235276A (ja) * 1995-12-27 1997-09-09 Takeda Chem Ind Ltd オキサゾール誘導体、その製造法および用途
AU1209497A (en) 1995-12-27 1997-07-28 Takeda Chemical Industries Ltd. Oxazole derivatives, their production and use
US5877193A (en) * 1996-07-19 1999-03-02 Hoffmann-La Roche Inc. Use of N-(4-aryl-thiazol-2-yl)-sulfonamides
AU740263C (en) 1996-07-22 2002-05-16 Monsanto Company Thiol sulfonamide metalloprotease inhibitors
US5703129A (en) 1996-09-30 1997-12-30 Bristol-Myers Squibb Company 5-amino-6-cyclohexyl-4-hydroxy-hexanamide derivatives as inhibitors of β-amyloid protein production
BR9713314A (pt) * 1996-10-11 2000-01-25 Warner Lambert Co Inibidores da enzima de conversão interleucina-1beta de ácido aspártico substituìdo com sulfonamida
US5985930A (en) 1996-11-21 1999-11-16 Pasinetti; Giulio M. Treatment of neurodegenerative conditions with nimesulide
EP0942923A2 (de) 1996-11-22 1999-09-22 Elan Pharmaceuticals, Inc. N(aryl/heteroaryl) aminosurederivate, diese anthaltende pharmazeutischezusammesetzungen, verfahren zur inhibierung amytoid peptide und deren freisetzung und produktion
DE19650196A1 (de) * 1996-12-04 1998-06-10 Bayer Ag Thienylsulfonylamino(thio)carbonylverbindungen
GB9725138D0 (en) * 1997-11-27 1998-01-28 Pharmacia & Upjohn Spa Thiophenesulfonamide compounds
JPH11343279A (ja) 1998-03-16 1999-12-14 Shionogi & Co Ltd スルホンアミド誘導体およびそれらを含有するＴＮＦ―α産生抑制剤
US5981168A (en) 1998-05-15 1999-11-09 The University Of British Columbia Method and composition for modulating amyloidosis
CN1295561A (zh) * 1998-06-03 2001-05-16 Gpinil控股公司 N－杂环羧酸或羧酸等排物的n－结合氨磺酰
US7410995B1 (en) 1998-08-14 2008-08-12 Gpi Nil Holdings Inc. N-linked sulfonamide of heterocyclic thioesters for vision and memory disorders
CA2366919A1 (en) 1999-02-26 2000-08-31 Merck & Co., Inc. Novel sulfonamide compounds and uses thereof
CN1347411A (zh) 1999-04-19 2002-05-01 盐野义制药株式会社 含有噁二唑环的磺酰胺衍生物
EP1088821A1 (de) 1999-09-28 2001-04-04 Applied Research Systems ARS Holding N.V. Pharmazeutisch wirksamer Sulfonamid Derivate
EP1088815A1 (de) * 1999-09-28 2001-04-04 Applied Research Systems ARS Holding N.V. Pharmaceutisch Aktive Sulfonyl-Aminosäurederivate
US6503901B1 (en) 1999-10-08 2003-01-07 Bristol Myers Squibb Pharma Company Amino lactam sulfonamides as inhibitors of Aβ protein production
US6657070B2 (en) * 2000-12-13 2003-12-02 Wyeth Production of chirally pure α-amino acids and N-sulfonyl α-amino acids
ATE330950T1 (de) * 2000-12-13 2006-07-15 Wyeth Corp Heterocyclische sulfonamide als inhibitoren der beta-amyloid-produktion
AU2002359519B2 (en) 2001-12-11 2009-07-16 Wyeth Process for the synthesis of chirally pure beta-amino-alcohols
AU2002351170B8 (en) 2001-12-11 2009-10-08 Wyeth Production of chirally pure alpha-amino acids and N-sulfonyl alpha-amino acids
NZ536665A (en) * 2002-06-11 2006-11-30 Wyeth Corp Use of substituted phenylsulfonamide as inhibitors of beta amyloid production
JP2006522126A (ja) * 2003-03-31 2006-09-28 ワイス βアミロイド生産のフルオロ含有およびトリフルオロアルキル含有複素環スルホンアミド阻害物質およびその誘導体

Also Published As

Publication number Publication date
US7842718B2 (en) 2010-11-30
CN1800176A (zh) 2006-07-12
EA009035B1 (ru) 2007-10-26
SG128491A1 (en) 2007-01-30
US20020183361A1 (en) 2002-12-05
TWI235155B (en) 2005-07-01
CY1105441T1 (el) 2010-07-28
ZA200304135B (en) 2004-09-03
NZ526213A (en) 2005-05-27
US7691884B2 (en) 2010-04-06
HUP0303857A3 (en) 2007-07-30
NO20032645L (no) 2003-08-05
NO328885B1 (no) 2010-06-07
CA2436526C (en) 2010-10-19
HUP0303857A2 (hu) 2004-03-29
PT1341779E (pt) 2006-10-31
EA200300674A1 (ru) 2004-06-24
BR0116063A (pt) 2004-08-03
AR035516A1 (es) 2004-06-02
NO20032645D0 (no) 2003-06-11
WO2002057252A2 (en) 2002-07-25
IL188853A0 (en) 2011-08-01
JP2004517892A (ja) 2004-06-17
CA2436526A1 (en) 2002-07-25
US20030229127A1 (en) 2003-12-11
US6610734B2 (en) 2003-08-26
ATE330950T1 (de) 2006-07-15
PL365950A1 (en) 2005-01-24
US6878742B2 (en) 2005-04-12
EP1341779B1 (de) 2006-06-21
HK1059619A1 (en) 2004-07-09
KR100869061B1 (ko) 2008-11-17
JP2010265280A (ja) 2010-11-25
DK1341779T3 (da) 2006-10-30
EP1341779A2 (de) 2003-09-10
AU2002245123B2 (en) 2007-05-24
CN1263750C (zh) 2006-07-12
US20110034513A1 (en) 2011-02-10
KR20040018318A (ko) 2004-03-03
US20050196813A1 (en) 2005-09-08
IL156268A0 (en) 2004-01-04
MXPA03005255A (es) 2004-10-14
US20100022594A1 (en) 2010-01-28
ES2267853T3 (es) 2007-03-16
NZ538100A (en) 2006-07-28
WO2002057252A3 (en) 2002-12-12
IL156268A (en) 2008-04-13
CN1503790A (zh) 2004-06-09
DE60121032T2 (de) 2007-01-11
SI1341779T1 (sl) 2006-12-31

Similar Documents

Publication Publication Date Title
DE60121032D1 (de) Heterocyclische sulfonamide als inhibitoren der beta-amyloid-produktion
DE60236226D1 (de) Verbesserung der Altersweitsichtigkeit
DE60103935D1 (de) Imidazol-5-yl-2-anilino-pyrimidine als inhibitoren der zellproliferation
DE60020100D1 (de) Dimerverbindungen und als inhibitoren der neuramidinase
AR028567A1 (es) Nuevos derivados de fenil-propargileter
NO20021207L (no) Nye spiroheterocykliske forbindelser nyttige som inhibitorer av cystein proteaser
ATE370938T1 (de) Pro-pharmakon von cox-2-inhibitoren
DE60321324D1 (de) Sulfonylaminoderivate als neue inhibitoren von histondeacetylase
DE60305061D1 (de) 2-pyridonderivate als inhibitoren von neutrophiler elastase
AR028596A1 (es) Nuevos derivados de fenilglicina
FI20011089A (fi) Informaation kommunikointi
ATE382042T1 (de) Sulfonamidderivate als wirkstoff-vorläufer von inhibitoren der aspartyl-protease
PT1086076E (pt) Inibidores de sulfonamida de aspartil protease
NO20013666D0 (no) Peptidyl heterosykliske ketoner nyttige som tryptase inhibitorer
DE60021194D1 (de) Phenylpiperazin-derivate als inhibitoren der serotonin-wiederaufnahme
ATE260274T1 (de) Furanonderivate als inhibitoren von cathepsin s
HK1070001A1 (en) Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors
DE60004017D1 (de) Heterocyclische benzolsulfonamidderivate als bradykinin antagonisten
ATE430726T1 (de) N-acylamino-benzyletherderivate als selektive inhibitoren der monoaminoxidase b
NO20023956L (no) Priperidin- og piperazinsubstituerte N-hydroksyformamider som inhibitorer av metalloproteinaser
PT1322592E (pt) Derivados substituidos de 1-aminobutan-3-ol
DE50115858D1 (de) Heterocyclische aminoalkylpyridinderivate als psychopharmaka
DE60031450D1 (de) Polymorph v von torasemid
EE200200389A (et) Imidasooli uued derivaadid
DE60235470D1 (de) N-heterocyclische inhibitoren der expression von tnf-alpha

Legal Events

Date Code Title Description
8364 No opposition during term of opposition